Mechanisms underlying 3-bromopyruvate-induced cell death in colon cancer

• Published in: Journal of bioenergetics and biomembranes Vol. 47; no. 4; pp. 319 - 329
• Main Authors: Sun, Yiming, Liu, Zhe, Zou, Xue, Lan, Yadong, Sun, Xiaojin, Wang, Xiu, Zhao, Surong, Jiang, Chenchen, Liu, Hao
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.08.2015; Springer Nature B.V
• Subjects: Animal Anatomy; Animal Biochemistry; Animals; Apoptosis; Autophagy; Autophagy - drug effects; Biochemistry; Bioenergetics; Bioorganic Chemistry; Cell death; Cell Line, Tumor; Chemistry; Chemistry and Materials Science; Chemotherapy; Colonic Neoplasms - drug therapy; Colonic Neoplasms - metabolism; Colonic Neoplasms - mortality; Colorectal cancer; Combined treatment; Energy Metabolism - drug effects; Female; Histology; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Morphology; Mortality; Organic Chemistry; Pyruvates - pharmacology; Xenograft Model Antitumor Assays; 3-Bromopyruvate; Necroptosis; ATP; Autophagy; Apoptosis
• ISSN: 0145-479X; 1573-6881
• DOI: 10.1007/s10863-015-9612-1

3-Bromopyruvate (3BP) is an energy-depleting drug that inhibits Hexokinase II activity by alkylation during glycolysis, thereby suppressing the production of ATP and inducing cell death. As such, 3BP can potentially serve as an anti-tumorigenic agent. Our previous research showed that 3BP can induce apoptosis via AKT /protein Kinase B signaling in breast cancer cells. Here we found that 3BP can also induce colon cancer cell death by necroptosis and apoptosis at the same time and concentration in the SW480 and HT29 cell lines; in the latter, autophagy was also found to be a mechanism of cell death. In HT29 cells, combined treatment with 3BP and the autophagy inhibitor 3-methyladenine (3-MA) exacerbated cell death, while viability in 3BP-treated cells was enhanced by concomitant treatment with the caspase inhibitor benzyloxycarbonyl-Val-Ala-Asp fluoromethylketone (z-VAD-fmk) and the necroptosis inhibitor necrostatin (Nec)-1. Moreover, 3BP inhibited tumor growth in a SW480 xenograft mouse model. These results indicate that 3BP can suppress tumor growth and induce cell death by multiple mechanisms at the same time and concentration in different types of colon cancer cell by depleting cellular energy stores.